Asthma Trial, Recruiting NCT07116460 Sponsor: Columbia University Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07116460
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers between 7 and 18 years old
  • People who have had asthma symptoms in the past 4 weeks
  • People living in lower-income housing in Northern Manhattan or the South Bronx area of New York City

Who may not be able to join:

  • People who are unable to complete the breathing tests required by the trial (called spirometry and FeNO tests)
  • Families who are planning to move home within the next year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthew S Perzanowski, PhD, Columbia University

Phone: (212) 305-3465

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 January 2026
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Fractional Exhaled Nitric Oxide (FeNO); Forced Expiratory Volume in 1 Second/ Forced Vital Capacity (FEV1/FVC) Ratio; Number of Attacks of Wheezing; Number of Emergency Department (ED) Visits

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov